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Abstract
Immune cell-type specific miRNA expression patterns have been described but the detailed role of single miRNAs in
the function of T-cells remains largely unknown. We investigated the role of miR-21 in the function of primary human
CD4+ T-cells. MiR-21 is substantially expressed in T-cells with a memory phenotype, and is robustly upregulated
upon αCD3/CD28 activation of both naive and memory T-cells. By inhibiting the endogenous miR-21 function in
activated naive and memory T-cells, we showed that miR-21 regulates fundamentally different aspects of T-cell
biology, depending on the differentiation status of the T-cell. Stable inhibition of miR-21 function in activated memory
T-cells led to growth disadvantage and apoptosis, indicating that the survival of memory T-cells depends on miR-21
function. In contrast, stable inhibition of miR-21 function in activated naive T-cells did not result in growth
disadvantage, but led to a significant induction of CCR7 protein expression. Direct interaction between CCR7 and
miR-21 was confirmed in a dual luciferase reporter assay. Our data provide evidence for a dual role of miR-21 in
CD4+ T cells; Regulation of T-cell survival is confined to activated memory T-cells, while modulation of potential
homing properties, through downregulation of CCR7 protein expression, is observed in activated naive T-cells.
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Introduction
Acquisition of effective, long-term immunity requires
development of memory CD4+ T-cells. This process, induced
by activation of a naive T-cell, involves extensive transcriptional
activity. Consequently, naive and memory T-cells are
characterized by distinct gene expression patterns [1,2].
However, not only the mere presence of transcripts, but also
their regulation e.g. by microRNAs (miRNAs) is crucial for
proper development and function of T-cells [3,4]. MiRNAs, a
class of small, single-stranded RNA molecules, regulate gene
expression at the post-transcriptional level. By binding to partly
complementary target sequences in the 3’ UTR of the mRNA,
miRNAs induce degradation or translational inhibition of the
targeted mRNA [5]. Like coding genes, expression of miRNAs
is dynamically regulated during activation and differentiation of
T-cells [6-8]. Consequently, various effector T-cell subsets are
characterized by distinct miRNA expression profiles [9,10].
However, the contribution of single miRNAs in the function of
individual T-cell subsets is still largely unknown.
Several miRNAs are highly expressed in freshly isolated
human memory CD4+ T-cells [9]. Amongst these, miR-21 has
anti-apoptotic properties which have been extensively studied
in pathological conditions including cancer, cardiovascular
disease and autoimmunity [11-14]. Indeed, miR-21 was
recently shown to suppress apoptosis and induce proliferation
of primary murine and human T-cells [15-18]. In accordance
with the pronounced expression in memory T-cells, it has been
shown that miR-21 can be induced upon activation of CD2+ T-
cells [6]. However, the kinetics and degree of miR-21
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upregulation, as well as the differential functional
consequences thereof in naive and memory T-cells remain
unknown.
In addition to apoptosis-related genes, bioinformatic analysis
[19,20] of putative miR-21 targets relevant for T-cell biology
revealed several immune-related genes, including CC-
chemokine receptor 7 (CCR7), which is substantially expressed
on naive T-cells [21]. By binding with its ligands (CCL19 and
CCL21) presented on the surface of high endothelial venules,
CCR7 enables entry of T-cells into lymph nodes, and as such
ensures (re)circulation of naive T-cells through the lymphatic
system (reviewed in 22).
In this study we focused on the physiological role of high
miR-21 expression in memory T-cells and the physiological
consequences of activation-induced miR-21 expression in
naive T-cells. By inhibiting endogenous miR-21 function during
activation we showed that the survival of CD4+ T-cells,
resulting from anti-apoptotic activity of miR-21, is confined
mostly to the memory T-cell compartment. In contrast,
activation-induced upregulation of miR-21 in naive T-cells post-
transcriptionally regulates expression of the lymph node
homing receptor CCR7. Thus, we provide evidence for a
divergent role of miR-21 in two key aspects of T-cell biology,
i.e. survival of memory T-cells and potential homing properties
of naive T-cells.
Results
MiR-21 expression is associated with memory T-cell
phenotype and is induced upon αCD3/CD28 activation
of CD4+ T-cells
MiR-21 expression was assessed in naive and memory
CD4+ T-cells isolated from PBMC of healthy volunteers (as
depicted in Figure S1A). The expression of miR-21 was
detectable in both T-cell subsets, and in agreement with
previous studies we observed that memory T-cells expressed
higher levels of miR-21 than naive T-cells (median fold
difference 5.1, p=0.016, Wilcoxon test) (Figure 1A). No
differences in miR-21 expression were observed between
central and effector memory T-cells, indicating that high miR-21
expression is a general feature of the memory T-cell phenotype
(Figure S1B-D). We next studied the kinetics of miR-21
induction upon T-cell activation. We assessed if and to what
extent αCD3/CD28 activation can induce miR-21 expression in
freshly isolated naive and memory T-cells. The expression of
miR-21 was strongly induced in response to activation of both
naive (median fold increase 13.8 at day 7, p<0.001, Friedman
test) and memory T-cells (median fold increase 4.6 at day 7,
p<0.001, Friedman test), indicating that miR-21 upregulation is
a general feature of T-cell activation (Figure 1B). Both T-cell
subsets responded to the stimulation in a similar manner in
regard to the increase in cell size (recorded by forward- and
side-scatter) and expression of IL-2 receptor α (CD25). By day
seven, all naive T-cells had obtained a memory phenotype as
defined by acquisition of CD45RO expression (Figure S1E and
F).
Figure 1.  MiR-21 expression is associated with memory T-cell phenotype and is induced upon αCD3/CD28 activation of
naive and memory T-cells.  A Baseline miR-21 expression was analyzed by qRT-PCR in naive (CD4+ CD45RO-) and memory
(CD4+ CD45RO+) T-cells isolated from PBMC of healthy volunteers. Relative expression normalized to the RNU48 reference gene
is shown. Each dot represents a separate donor. Lines represent median values (n=7, Wilcoxon signed ranked test). B MiR-21
expression was analyzed by qRT-PCR in naive (CD4+ CD45RO-) and memory (CD4+ CD45RO+) T-cells before (day 0), and at
indicated time points after activation with plate-bound-anti-CD3/soluble-anti-CD28 mAbs. Relative expression normalized to the
RNU48 reference gene is shown. Data are expressed as median with interquartile range (n=6 donors, statistical analysis inside the
T-cell subset: Friedman test, with a Dunn’s Multiple Comparison test). *p<0.05, **p<0.01, ***p<0.0001.
doi: 10.1371/journal.pone.0076217.g001
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MiR-21 mediates survival of activated memory CD4+ T-
cells
To determine the functional role of activation-induced miR-21
expression we stably inhibited its function using a lentiviral-
based, antisense miR-21 expression system (miR-21 inhibitor,
Figure S2A) in activated naive and memory T-cells. To assess
if miR-21 inhibition affects the growth of activated T-cells, we
performed a competition assay in which the percentage of GFP
+ cells, harboring miR-21 or control inhibitor (a scrambled
hairpin sequence), was monitored over 15 to 18 days in mixed
GFP+ and GFP- cell cultures (as schematically depicted in
Figure S2B). MiR-21 inhibition in activated naive T-cells led to
a subtle, but consistent decrease in the percentage of GFP+
cells only at the beginning of the assay (day 8), and then
remained stable until day 18 (Figure 2A, B). In contrast, miR-21
inhibition in activated memory T-cells led to a continuous
depletion of GFP+ cells over time, indicating that survival of
memory T-cells relies on the presence of miR-21 (Figure 2C,
D). To assess if the observed growth disadvantage results from
increased apoptosis, we FACS isolated GFP+ cells harboring
miR-21 or control inhibitor at day six following transduction, and
assessed apoptosis after an additional 48h culture period.
Analysis of the loss of mitochondrial transmembrane potential
revealed an increased apoptosis rate in both naive (Figure 2E)
and memory (Figure 2F) T-cells harboring miR-21 inhibitor. The
increase was most pronounced in the memory T-cells,
indicating that activation-induced miR-21 expression is an
important anti-apoptotic factor for T-cells in general, but is
especially necessary for the maintenance of activated memory
T-cells.
MiR-21 regulates expression of CC-chemokine receptor
7 (CCR7)
Since miR-21 appeared to function differently in naive and
memory T-cells, we next set out to study the functional role of
miR-21 in activated naive T-cells. To this end, we examined the
effect of miR-21 inhibition on specific aspects of the transition
from a naive to a memory phenotype by analyzing the
expression of CD45RA, CD45RO and CCR7, defining naive,
central and effector memory T-cell stages [21], as well as the
expression of CD25 on resting naive, and on activated GFP+
T-cells. Changes in the expression of CD45RA, CD45RO and
CD25 resulting from the activation, were similar in T-cells
harboring miR-21 and control inhibitor (Figure S2C). In
contrast, the expression of CCR7 was significantly increased
on activated naive T-cells harboring miR-21, but not control
inhibitor (Figure 3A). The increase in the expression of CCR7
was evident at the level of CCR7 expression per cell (defined
as geometric mean fluorescent intensity of the staining: MFI,
Figure 3B), and in the amount of CCR7 positive cells in the
culture (Figure 3C). A similar result was observed at the CCR7
transcript level (Figure 3D). The expression of CCR7 protein on
memory T-cells harboring miR-21 inhibitor was also increased
at day six after transduction, however to a significantly lesser
extent than in naive T-cells (median fold increase 2.4 and 4.1
respectively) and with more variation between different donors
(Figure 3E-H). The miRNA target prediction programs
TargetScan (www.targetscan.org/) [19] and MicroCosm
Targets (www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/
v5/) [20] denote a conserved miR-21 binding site in the 3’ UTR
of the human CCR7 transcript suggesting a direct interaction
between the CCR7 transcript and miR-21 (Figure S2D). Co-
transfection of a dual luciferase reporter construct harboring
the 3’ UTR of CCR7 together with miR-21 precursor molecules
resulted in a significant decrease of the relative luciferase
levels. This indicates that CCR7 is indeed a direct target of
miR-21 (Figure 4A). In agreement, freshly isolated naive and
memory T-cells showed inversed miR-21 and CCR7
expression patterns (Figure 4B). In addition, αCD3/CD28
activation of isolated naive T-cells led to a significant
downregulation at the CCR7 protein level (Figure 4C-E), in
spite of increased CCR7 transcript levels (Figure 4F), which
also indicates a post-transcriptional regulation of CCR7 protein
expression. Together these data show that activation-induced
miR-21 expression (Figure 1B) negatively regulates CCR7
protein levels, especially in activated naive T-cells.
Discussion
In this study we show that activation-induced miR-21 is an
integral part of the T-cell activation process where it co-
regulates fundamentally different aspects of T-cell biology
depending on the differentiation status of the T-cell.
Specifically, we show that miR-21 regulates the potential
migration capacity and transition towards the memory T-cell
phenotype of activated naive T-cells, and supports survival of
activated memory T-cells. Likely, the different gene expression
profiles characterizing naive and memory T-cells [23,24] are
fundamental to the observed dual functionality of miR-21.
MiRNAs can theoretically regulate a multitude of diverse target
genes, however, only a fraction of the predicted target genes is
co-expressed together with the miRNA in a given cell type and,
as such, can be subjected to miRNA-based regulation.
Moreover, the miRNA-target gene interaction is also affected
by the presence of other target genes, which are competing for
the same miRNA [5,25]. Thus, the overall miRNA-target gene
expression ratio, and the abundance of individual target genes
are likely of central importance for the factual miRNA-based
regulation.
MiR-21 levels are substantially higher in ex vivo isolated
memory T-cells than in naive T-cells (this study and [9,10]).
Sub division of memory T-cells into central and effector
memory phenotypes did not reveal any differences in miR-21
expression, indicating that high miR-21 levels are a general
feature of the memory T-cell phenotype. It would be interesting
to study miR-21 expression also in terminally differentiated (i.e.
CD45RO-CCR7-) T-cells, which are virtually absent in the
CD4+ population but present in the CD8+ population.
MiR-21 expression is significantly induced upon T-cell
activation in both naive and memory T-cells. However, we
found that memory T-cells upregulate miR-21 more rapidly and
achieve higher levels of expression, indicating a more
prominent role of miR-21 in this population. Expression of the
primary-miR-21 transcript can be induced by mitogenic stimuli,
such as phorbol-12-myristate-13-acetate (PMA) in several
cancer cell lines, and is under positive transcriptional control of
Dual Role of miR-21 in CD4+ T-Cells
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Figure 2.  MiR-21 mediates survival of activated memory CD4+ T-cells.  A Resting naive (CD3+ CD8-CD45RO-CD25-) T-cells
were stimulated with 5µg/ml PHA and 100 U/mL IL-2, followed by transduction with lentiviral vectors harboring miR-21 or control
inhibitor (scrambled hairpin sequence) and GFP. The percentage of GFP+ cells in culture over time was monitored by FACS. Data
were normalized to the first measurement at day six. Each line represents a separate donor (n=5, two-way RM ANOVA with
Bonferroni posttests, ns-not significant). B Data from A, depicted as median values with interquartile range. C Resting memory
(CD3+ CD8-CD45RO-CD25-) T-cells were stimulated with 5µg/ml PHA and 100 U/mL IL-2, followed by transduction with lentiviral
vectors harboring miR-21 or control inhibitor (scrambled hairpin sequence) and GFP. The percentage of GFP+ cells in culture over
time was monitored by FACS. Data were normalized to the first measurement at day six. Each line represents a separate donor
(n=5, two-way RM ANOVA with Bonferroni posttests). D Data from C, depicted as median with interquartile range. E Activated
naive, and F activated memory GFP+ T-cells harboring miR-21 or control inhibitor were isolated by FACS from mixed cultures (A,
and C respectively) at day six post lentiviral transduction. Isolated GFP+ cells, and activated not transduced cells (NT) were cultured
in complete media supplemented with 100 U/mL of IL-2 for 48h (until day 8), and percentage of apoptotic cells was assessed by
FACS-based measurement of mitochondrial trans-membrane potential loss, using DilC1(5). Each line represents a separate donor
(naive: n=4, memory n=5, RM ANOVA with Bonferroni posttests). *p<0.05, **p<0.01, ***p<0.0001.
doi: 10.1371/journal.pone.0076217.g002
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AP-1, STAT3 and NF-kB [26-29]. Two of these transcription
factors, AP-1 and NF-κB, are directly downstream of the TcR/
CD28 and PKC signaling pathways [30,31], and as such may
be responsible for the observed miR-21 induction following T-
cell activation. Indeed, we observed an almost complete
ablation of activation-induced miR-21 expression upon PKC
inhibition (data not shown).
Previous studies in mice and man have shown the
involvement of miR-21 in T-cell survival in general [15,18]. Our
data, discriminating between naive and memory T-cells,
indicate that the requirement for miR-21-based regulation of T-
Figure 3.  MiR-21 inhibition leads to increased CCR7 expression in activated T-cells.  A Representative FACS staining plot
depicting CCR7 expression on resting naive (CD3+ CD8-CD45RO-CD25-, Day 0), and on PHA/IL-2 activated, GFP+ cells harboring
miR-21 or control inhibitor (scrambled hairpin sequence) at day six post lentiviral transduction. The isotype staining control is
depicted. B Quantification of CCR7 staining of GFP+ cells from A, depicted as MFI (geometric mean fluorescent intensity). Each line
represents a separate donor (n=8, Wilcoxon signed ranked test). C Percentage of CCR7 positive, GFP+ cells from A. Each line
represents a separate donor (n=8, Wilcoxon signed ranked test). D GFP+, PHA/IL-2 activated naive T-cells harboring miR-21 or
control inhibitor were FACS isolated at day six post-lentiviral transduction and CCR7 transcript expression was determined by qRT-
PCR. Each line represents a separate donor (n=3, paired t-test, ns). Relative expression normalized to the U6 reference gene is
shown. E Representative FACS staining plot depicting CCR7 expression on resting memory (CD3+ CD8-CD45RO+CD25-, Day 0),
and on PHA/IL-2 activated, GFP+ cells harboring miR-21 or control inhibitor (scrambled hairpin sequence) at day six post lentiviral
transduction. The isotype staining control is also depicted. F Quantification of CCR7 staining of GFP+ cells from E, depicted as MFI
(geometric mean fluorescent intensity). Each line represents a separate donor (n=7, Wilcoxon signed ranked test). G Percentage of
CCR7 positive, GFP+ cells from E. Each line represents a separate donor (n=7, Wilcoxon signed ranked test). D GFP+, PHA/IL-2
activated memory T-cells harboring miR-21 or control inhibitor were FACS isolated at day six post-lentiviral transduction and CCR7
transcript expression was determined by qRT-PCR. Each line represents a separate donor (n=3, paired- t-test, ns). Relative
expression normalized to the U6 reference gene is shown. *p<0.05, **p<0.01.
doi: 10.1371/journal.pone.0076217.g003
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cell survival is largely restricted to T-cells with a memory
phenotype. Although induction of apoptosis was observed in
both activated naive and memory T-cells early after miR-21
inhibition, continuous depletion of T-cells was observed only in
the memory T-cell cultures. Stagakis et al. have recently
reported that miR-21 affects T-cell proliferation [16]. Therefore
it is possible, that the observed loss of memory T-cells lacking
miR-21 is the result of enhanced apoptosis combined with a
reduced proliferation rate. However, we did not observe a clear
effect of miR-21 inhibition on the proliferative potential of either
naive or memory T-cells (data not shown). In vivo studies are
warranted to further study the details of the observed
differential response of naive and memory T-cells towards the
inhibition of miR-21 expression, especially in relation to defined
aspects of long-term memory T-cell survival.
Figure 4.  CCR7 is a direct target of miR-21 and correlates inversely with miR-21 expression in resting and activated T-
cells.  A Ratio of Renilla luciferase (RL) to firefly luciferase (FL) signal, determined in lysates of Cos-7 cells co-transfected with
psiCHECK-2 construct harboring the CCR7 3’ UTR and a synthetic miR-21 or control precursor. Median values with range of data
normalized to control precursor are depicted (n=4 independent experiments, paired t-test). B MiR-21 and CCR7 expression levels
were assessed by qRT-PCR in freshly isolated naive (CD4+ CD45RO-) and memory (CD4+ CD45RO+) T-cells. Expression levels
are shown relative to the RNU48 and U6 reference genes respectively. Each line represents a separate donor (n= 8, Wilcoxon
signed ranked test). C Representative FACS staining plot depicting CCR7 expression on isolated naive (CD4CD45RO-) T-cells
before (day 0), and after seven days of activation with plate-bound-anti-CD3/soluble-anti-CD28 mAbs. Isotype staining is depicted.
D Quantification of CCR7 staining from C, depicted as MFI (geometric mean fluorescent intensity). Each line represents a separate
donor (n=3, paired t-test, ns). E Percentage of CCR7 positive, GFP+ cells from C. Each line represents a separate donor (n=3,
paired t-test). F CCR7 transcript expression was determined by qRT-PCR in naive (CD4+ CD45RO-) T-cells before (day 0), and
after seven days of activation with plate-bound-anti-CD3/soluble-anti-CD28 mAbs. Each line represents a separate donor (n=5,
paired t-test). Expression levels shown in the graph are normalized to the U6 reference gene. *p<0.05, **p<0.01.
doi: 10.1371/journal.pone.0076217.g004
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Stable inhibition of miR-21 in activated naive T-cells led to a
significant upregulation of CCR7. To our knowledge this is the
first report describing direct, miRNA-driven post-transcriptional
regulation of CCR7 expression in human T-cells. It has been
previously shown that the expression of CCR7 is
downregulated following T-cell activation, and that activated T-
cells within secondary lymphoid organs express lower levels of
CCR7 protein [32,33]. Furthermore, decreased expression of
CCR7, which is paralleled by increased expression of CXCR5,
has been shown to guide activated T-cells out of the T-cell
areas of the lymph node and direct them towards the B-cell
follicles [34]. We found that activation-induced expression of
miR-21 regulates CCR7 especially in naive T-cells. Therefore,
we propose that fine-tuning of CCR7 expression by miR-21,
following the activation of naive T-cells, enhances the egress of
activated T-cells from the T-cell rich areas of the lymph nodes,
and prevents consecutive recycling through other lymph nodes.
The induction of miR-21 upon activation of naive T-cells is thus
an inherent part of T-cell programming, which is actively
associated with quelling of the naive T-cell state and induction
of the memory T-cell phenotype. Regulation of CCR7 in
activated (central) memory T-cells was also observed,
however, to a much lesser extent than in naive T-cells, and
with more variability between the donors. It is likely that
abundant expression of other miR-21 target genes prevents
regulation of CCR7 in central memory T-cells, and that the
miR-21 targetome in different T-cell subsets varies based on
the overall expression pool of potential miR-21 target genes. Of
note, bioinformatics analysis revealed no miR-21 binding site in
the 3’ UTR of the murine CCR7 transcript, denoting possible
fundamental differences between the regulation of CCR7 in
mice and man.
Together, our results provide evidence that miR-21
differentially affects naive and memory T-cells. We propose
that intrinsic, phenotype-specific differences between these two
T-cell subsets, e.g. depending on the miRNA-mRNA target
gene balance, dictate the outcome of miR-21 function.
Materials and Methods
Ethics statement
The study was approved by The Medical Ethical Committee
(METC) of the University Medical Center Groningen (UMCG)
(project number: 2009.118) and written informed consent was
obtained from all donors.
PBMC isolation
Peripheral blood mononuclear cells (PBMC) from healthy
donors were isolated immediately after blood withdrawal into
heparin-containing vacutainer tubes (Becton Dickinson,
Franklin Lakes, USA). Isolation was done by density gradient
centrifugation of diluted blood (1:1 PBS) using Lymphoprep
(Axis-shield, Oslo, Norway) according to the manufacturer
instructions.
Isolation and culture of CD4+ T-cell subsets
Naive (CD4+ CD45RO-) and memory (CD4+ CD45RO+)
(Figure 1A, B; Figure 4B-F; Figure 1A, E, F); naive (CD4+
CD45RO-CCR7+), central memory (CD4+ CD45RO+ CCR7+)
and effector memory (CD4+ CD45RO+ CCR7-) (Figure 1B, C,
D); as well as resting naive (CD3+ CD8-CD45RO-CD25-) and
resting memory (CD3+ CD8-CD45RO+CD25-) T-cells (Figure
2A-F; Figure 3A-H; Figure 2C) were isolated from PBMC of
healthy donors by fluorescence-activated cell sorting (FACS)
(MoFlo, Beckman Coulter, Brea, USA) using staining with
monoclonal antibodies (mAbs) against human: CD4-FITC
(Edu-2), CD8-FITC (MCD8, both from IQ Products, Groningen,
The Netherlands), CD4-eFluor-450 (RPA-T4), CD45RO-PE
(UCHL1), CD3-eFluor-450 (OKT-3), CD25-APC (BC96, all from
eBioscience, San Diego, USA), CCR7-biotinylated (3D12, BD
Biosciences) and APC-labeled streptavidin (Biolegend, San
Diego, CA, USA). Cells used for assessment of baseline
miR-21 expression were directly lysed with Qiazol reagent
(Qiagen, Venlo, The Netherlands), and stored at -20°C until
RNA extraction procedure. Isolated CD4+ T-cell subsets were
cultured in RPMI 1640 with L-glutamine supplemented with
10mg/ml gentamycin and 5% Human Serum AB (all from
Lonza, Basel, Switzerland) (complete media), at 37°C in 5%
CO2. Prior to lentiviral transduction cells were stimulated for
24h in complete media supplemented with 5µg/ml
phytohaemaglutinin (PHA, Thermo, Fisher Scientific Remel
products, Lenexa, USA) and 100U/mL recombinant human IL-2
(Peprotech, London, England). Following lentiviral transduction
cells were cultured in complete media supplemented with
100U/mL recombinant human IL-2 (Peprotech).
Cell lines
COS-7 cells (African Green Monkey SV40-transformed
kidney fibroblast cell line) and HEK293T cells (SV40 Large T-
antigen-transformed human embryonic kidney cell line) were
cultured in Dulbecco modified Eagle medium (DMEM)
supplemented with 10% FBS, 200mM L-glutamine and
10mg/ml gentamycin (Lonza) at 37°C in 5% CO2. Both cell
lines were obtained from ATCC.
T-cell activation with αCD3/CD28 mAbs
TCR stimulation of isolated naive (CD4+ CD45RO-) and
memory (CD4+ CD45RO+) T-cells was performed with plate-
bound anti-human-CD3 and soluble anti-human-CD28 mAbs.
Briefly, culture plates were incubated with goat-anti-mouse-
IgG2a Ab (Cat. No. 1080-01, Southern Biotechnology)
overnight at 4°C, followed by washing with PBS and 1h
incubation with hybridoma-culture supernatant, containing anti-
human-CD3 IgG2a mAb (clone WT32, approx. conc. 1µg
IgG/mL) at RT. Unbound anti-CD3 antibody was removed by
washing 4 times with excess PBS, and isolated CD4+ T-cell
subsets were seeded at the density of 0.5x106 cells/mL in
complete medium supplemented with 5% V/V hybridoma-
culture supernatant containing anti-human CD28 IgG1 mAb
(clone 20-4669), giving about 0.1µg IgG/mL end concentration.
Cells were re-stimulated every 2-3 days. At indicated time
points, cells were harvested, stained for FACS analysis or
Dual Role of miR-21 in CD4+ T-Cells
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lysed with the Qiazol reagent (Qiagen) and stored at -20°C until
RNA extraction procedure.
FACS analysis of cell surface markers
Expression of cell-surface markers on T-cell subsets before
and after treatment with activating stimuli was assessed by
FACS using mAbs against human CD45RO-PE (UCHL1),
CD25-APC (BC96), CD45RA-eFluor605 (HI100, all from
eBioscience), and CCR7-PE-Cy7 (3D12) or rat-IgG2a-PE-Cy7
isotype control (R35-9, both from BD Biosciences). To assess
CCR7 expression, cells were incubated with mAb for 30min at
RT. Cells were measured on BD LSR-II Flow Cytometer using
Diva software (BD Biosciences) (Figure 3, Figure 2C) and on
FACS Calibur flow cytometer using Cell Quest software (BD
Biosciences) (Figure 4, Figure 1E, F). Data were analyzed
using the Kaluza Flow Analysis Software (Beckman Coulter).
RNA Isolation and qRT-PCR
Total cellular RNA was extracted using the miRNeasy Mini
Kit (Qiagen, Venlo, The Netherlands) following the
manufacturer’s instructions. The RNA quantity was measured
on a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, DE). Gene expression levels were
analyzed by quantitative reverse-transcription-polymerase
chain reaction (qRT-PCR). For miRNA-specific cDNA
synthesis, RNA was reverse transcribed using the Taqman
MicroRNA Reverse Transcription kit in combination with
multiplexed reverse transcription primers of TaqMan microRNA
Assays (Life Technologies, Carlsbad, USA): for miR-21 (ID:
000397) and RNU48 (ID: 001006). cDNA synthesis for mRNA
was performed using Superscript III RTase (Life Technologies).
The qPCR reaction was performed using qPCR MasterMix
Plus (Eurogentec, Liege, Belgium), and Taqman Gene
expression assay for detection of CCR7: Hs01013469_m1 (Life
Technologies), or gene specific primers and probe for detection
of U6. Forward primer: 5’-
TGGAACGATACAGAGAAGATTAGCA-3’, reverse primer: 5’-
AAAATATGGAACGCTTCACGAATT-3’, and probe: 5’-6-FAM-
CCCTGCGCAAGGATGACACGC-TAMRA-3’ (Integrated DNA
Technologies, Coralville, USA.) RNU48 served as endogenous
control for miR-21, while U6 served as endogenous control for
CCR7. All reactions were run in triplicate. Mean cycle threshold
(Ct) values for all genes were quantified with the Sequence
Detection Software (SDS, version 2.3, Life Technologies),
using ABI7900HT thermo cycler (Life Technologies). Relative
expression levels were determined using the 2-ΔCt formula,
where ΔCt = Ctgene – Ctref.gene.
Production of viral particles, stable transduction and
GFP expression assessment
Viral particles were produced by calcium phosphate
(CaPO4)-mediated transfection of HEK293T cells with
pmiRZip-21, lentiviral miR-21 inhibition vector (miR-21 inhibitor)
(Cat. Nr MZIP21-PA-1), or pmiRZip-scrambled hairpin, lentiviral
control inhibitor vector (control-inhibitor) (Cat. Nr MZIP000-
PA-1, both from Systems Biosciences, Mountain View, USA)
together with pCMV-Δ8.91 and pMD2.G expression vectors in
ratio of 4:4:1. Lentiviral particles were collected 48h after
transfection and passed through a 0.45µm Millex-HV filter
(Millipore, Billerica, USA). Isolated, resting naive (CD3+ CD8-
CD45RO-CD25-) and memory (CD3+ CD8-CD45RO+CD25-)
T-cells (1x106 cells/ml) were stimulated with 5µg/ml PHA
(Thermo, Fisher Scientific Remel products) and 100U/mL
recombinant human IL-2 (Peprotech) for 24h prior to
transduction. Lentiviral transduction was carried out for 24h in
the presence of 4µg/ml polybrene (Sigma-Aldrich, St. Louis,
USA). After viral transduction, cells were washed three times
with PBS and cultured in complete media supplemented with
100U/mL recombinant human IL-2 (Peprotech, London,
England). The expression of green fluorescent protein (GFP) in
mixed cultures was measured on a FACS Calibur flow
cytometer (BD Biosciences), and monitored for up to 18 days.
The percentage of GFP positive cells at the beginning of the
assay (day 6) was set to one, and a fold difference per
measurement was calculated. Transduced cells were sorted
based on the GFP expression using MoFlo sorter (Beckman
Coulter), or kept in mixed cultures for competition assay.
Apoptosis measurement
Activated naive and memory GFP+ T-cells harboring miR-21
or control inhibitor were isolated by FACS from mixed cultures
at day six post lentiviral transduction, and seeded in 96-wells
plates in complete media supplemented with 100 U/mL of IL-2.
Control, not transduced cells cultured under the same
conditions were seeded alongside. Percentage of apoptotic
cells was assessed after 48h (day 8) by FACS-based
measurement of mitochondrial transmembrane potential loss.
Briefly, cells were stained for 20min at 37°C in cell culture
medium containing 50nM DilC1(5) compound (Enzo Life
Sciences, NY, USA), followed by washing with PBS. Cells were
kept on ice and measured directly at the FACS Calibur flow
cytometer using Cell Quest software (BD Biosciences). Data
were analyzed using Kaluza Flow Analysis Software (Beckman
Coulter).
Cloning of reporter construct, transient transfection
and luciferase assays
The 3’ UTR sequence harboring the putative miRNA binding
site and a part of the open reading frame of the human CCR7
transcript was PCR-amplified from genomic DNA using primers
harboring an XhoI (5’) or NotI (3’) restriction site: 5’-
TTGCTCGAGGAGACCACCACCACCTTCTC-3’ (forward) and
5’-TGGCGGCCGCCAGTGGAGCCAAGAGCTGAG-3’
(reverse), and cloned into psiCHECK2 vector (Promega,
Madison, USA), as described previously [35]. The insert was
sequence verified (BaseClear, Leiden, The Netherlands).
Cos-7 cells (1,2x104) were transfected with 125ng of the
psiCHECK2 construct and 50nM Pre-miR-21 miRNA Precursor
Molecule ID: PM10206 or Pre-miR miRNA Precursor Negative
Control 1 (Life Technologies) using the Saint-MIX compound
(Synvolux Therapeutics B.V., Groningen, The Netherlands) in
250µl serum-free medium. Four hours following the
transfection, 500µl of medium supplemented with 10% FBS
was added. Cells were lysed 24h after transfection and Renilla
and Firefly luciferase activity was measured using the Dual-
Luciferase Reporter Assay System (Promega) according to
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manufacturer’s instructions. For each transfection, luciferase
activity was measured in duplicate with the Luminoskan Ascent
Microplate Luminometer (Thermo Scientific). The Renilla over
Firefly (RL/FF) luciferase ratio for miR-21 precursor was
calculated. The RL/FF ratio of control precursor was set to one.
Statistical analysis
Statistical analyses were performed in the GraphPad Prism
software (version 5.0). Comparisons of paired samples were
performed using the Wilcoxon signed-rank test. Comparisons
of paired samples with less than six replicates were performed
using the paired t-test or with repeated measures (RM) ANOVA
with Bonferroni posttests. Assessment of response to the
stimuli over time was performed by the Friedman test with a
Dunn’s Multiple Comparison test. Comparisons of response to
treatment over time between two groups were performed by
the Two-way Repeated Measures ANOVA with Bonferroni
posttests. All statistical analyses were two-sided, and the
significance level used was p < 0.05.
Supporting Information
Figure S1.  Isolation and activation of primary human naive
and memory CD4+ T-cells. A Representative FACS plot
depicting gates used for isolation of naive (CD4+ CD45RO-)
and memory (CD4+ CD45RO+) T-cells. B Percentage of naive
(CD45RO-/CCR7+), central memory (CD45RO+ CCR7+),
effector memory (CD45RO+ CCR7-), and terminal effector
(CD45RO-CCR7-) T-cells within CD4+ T-cell population,
assessed by FACS, is shown. Bars represent median values
with range (n=5 donors). C Representative FACS plot depicting
gates used for purification of naive, central memory and
effector memory CD4+ T-cells. D Baseline miR-21 expression
analyzed by qRT-PCR in naive, central memory and effector
memory CD4+ T-cells purified from PBMC of healthy
volunteers. Each dot represents a separate donor. Lines
represent median values (n=4, RM ANOVA with a Bonferroni
posttests). Relative expression, normalized to the RNU48
reference gene is shown. E, F Representative FACS plots
depicting phenotypic analysis of naive (CD4+ CD45RO-) E,
and memory (CD4+ CD45RO+) F T-cells before (day 0) and
after seven days of activation with plate-bound-anti-CD3/
soluble-anti-CD28 mAbs.
(TIF)
Figure S2.  Representation of miR-21 inhibition and
analysis. A Schematic outline of lentiviral vector used for the
inhibition of endogenous miR-21 function. Adapted from
miRZips™ Lentiviral-based MicroRNA Inhibition system,
Systems Biosciences. B Schematic representation of the GFP
competition assay. C Representative FACS staining plots
depicting expression of CD45RA, CD45RO, and CD25 on
resting naive (CD3+ CD8-CD45RO-CD25-, Day 0), and on
GFP+ activated T-cells, harboring miR-21 or control inhibitor,
six days post lentiviral transduction. D Schematic indication of
the miR-21 binding site in the 3’ UTR of the CCR7 gene and
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